Lumentum Holdings is heading into its August 11 earnings with a notable divergence: the stock just posted its best week in months, yet short sellers are adding positions and options traders just registered their most defensive posture of the year.
The stock gained 17% this week to close at $814.80, bouncing sharply after a rough month that saw it shed nearly 12%. The weekly move dwarfs close peers — AAOI rose 10% and CIEN gained 7%, while VIAV managed just 4%. Lumentum led the optical networking group by a clear margin, suggesting the rally reflects something specific to the name rather than a broad sector lift.
The clearest tension in the data is between a surging price and a short book that is still being built. Short interest climbed 3.2% this week to 13.4% of free float — a high absolute level, and one that has now risen roughly 10% over the past month. That divergence between a rising stock and a growing short position is the setup worth watching. What makes it less alarming from a squeeze-pressure standpoint is the lending environment: borrow availability is extremely loose at over 1,130% — more than eleven shares available for every one currently shorted — and cost to borrow is running at just 0.37%, down sharply from levels seen a month ago. Short sellers face no meaningful friction in maintaining or expanding positions. Where options tell a starkly different story: the put/call ratio jumped to 1.31 on July 14, nearly three standard deviations above its 20-day average of 1.00, and close to the 52-week high of 1.33. That single-day spike in downside hedging demand — after weeks of near-flat PCR readings around 0.95 — reads as a defensive response to the size of the weekly rally rather than a structural bearish shift.
The Street is more cautious than the options move alone would suggest. TD Cowen cut its price target to $800 on July 13 — almost exactly at the current price — while holding a Hold rating, a signal that at least one bellwether firm sees limited further upside at current levels. That stands in contrast to the post-May earnings wave, when JPMorgan raised its target to $1,130, Barclays moved to $1,000, and UBS more than doubled its target to $960. The consensus mean sits near $1,103, implying roughly 35% upside from here. EPS momentum is strong — ranking in the 86th percentile on a 30-day basis and 83rd on a 90-day basis — while the forward EPS growth score (22nd percentile) and short score rank (25th percentile) suggest the market is not pricing in that momentum cleanly. The P/E multiple has contracted about 13 points over the past 30 days, reflecting the stock's pullback from its highs rather than any fundamental deterioration.
The insider picture adds a layer of context that is worth acknowledging. Every recorded trade in the past 90 days has been a sale: the CFO, an Executive VP, a divisional President, and multiple directors all sold between mid-May and early June, at prices ranging from roughly $855 to $1,000. The aggregate net value of sales over 90 days runs close to $48 million. None of the individual trades carry a high significance score, and the sales came largely in the $940–$1,000 range — well above where the stock sits today — suggesting at least some of the selling was opportunistic after the post-earnings pop. There is no buying on record to offset the pattern.
On recent earnings history, the stock has fallen 3–4% in the session immediately following each of the last two prints, before recovering over the subsequent five days. The five-day bounce averaged roughly 4% across those events. With the next release set for August 11, that pattern is worth keeping in mind — particularly given that short interest is elevated and the options market moved sharply defensive on the day the stock posted its biggest weekly gain.
The setup heading into August is therefore less about whether Lumentum's AI datacentre demand story is intact, and more about whether the current price — still 26% below the consensus target but also well off the June highs — is where shorts and options hedgers will press harder or back away.
See the live data behind this article on ORTEX.
Open LITE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
